当前位置:首页 - 行情中心 - 川宁生物(301301) - 财务分析 - 现金流量表

川宁生物

(301301)

  

流通市值:60.23亿  总市值:217.43亿
流通股本:6.18亿   总股本:22.30亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金577,902,889.733,372,852,789.692,759,760,332.741,617,175,171.52
  收到的税费返还1,610,619.57,752,108.422,932,581.56-
  收到其他与经营活动有关的现金18,380,743.11106,323,178.8164,561,162.1235,719,213.04
  经营活动现金流入小计597,894,252.343,486,928,076.922,827,254,076.421,652,894,384.56
  购买商品、接受劳务支付的现金155,293,761.151,834,727,762.281,397,070,411.12623,684,186.24
  支付给职工以及为职工支付的现金168,207,053.62497,582,852.28371,438,880.45266,613,711.34
  支付的各项税费85,067,170.75524,858,829.31462,680,179.51346,751,292.02
  支付其他与经营活动有关的现金6,645,330.8780,699,154.7225,123,340.0324,361,426.56
  经营活动现金流出小计415,213,316.392,937,868,598.592,256,312,811.111,261,410,616.16
  经营活动产生的现金流量净额182,680,935.95549,059,478.33570,941,265.31391,483,768.4
二、投资活动产生的现金流量:
  收回投资收到的现金550,606,794.642,791,038,607.771,920,903,734.05960,449,358.05
  取得投资收益收到的现金-01,126,793.431,115,193.43
  处置固定资产、无形资产和其他长期资产收回的现金净额-154.87--
  投资活动现金流入小计550,606,794.642,791,038,762.641,922,030,527.48961,564,551.48
  购建固定资产、无形资产和其他长期资产支付的现金17,049,007.7197,211,603.862,973,255.6724,203,403.74
  投资支付的现金603,000,0002,925,759,277.782,161,029,277.78982,360,666.67
  支付其他与投资活动有关的现金6,830---
  投资活动现金流出小计620,055,837.713,022,970,881.582,224,002,533.451,006,564,070.41
  投资活动产生的现金流量净额-69,449,043.07-231,932,118.94-301,972,005.97-44,999,518.93
三、筹资活动产生的现金流量:
  吸收投资收到的现金-20,135,52020,135,52012,935,520
  其中:子公司吸收少数股东投资收到的现金-7,200,0007,200,000-
  取得借款收到的现金200,000,000747,990,436.81499,989,863.01-
  筹资活动现金流入小计200,000,000768,125,956.81520,125,383.0112,935,520
  偿还债务支付的现金346,000,000817,333,333510,333,33325,333,333
  分配股利、利润或偿付利息支付的现金5,937,913.05622,104,954.13618,269,188.56613,781,953.06
  支付其他与筹资活动有关的现金26,879,329.62,603,515.2577,615.2577,615.2
  筹资活动现金流出小计378,817,242.651,442,041,802.331,129,180,136.76639,692,901.26
  筹资活动产生的现金流量净额-178,817,242.65-673,915,845.52-609,054,753.75-626,757,381.26
四、汇率变动对现金及现金等价物的影响-5,105,726.252,670,112.452,265,910.673,203,527.39
五、现金及现金等价物净增加额-70,691,076.02-354,118,373.68-337,819,583.74-277,069,604.4
  加:期初现金及现金等价物余额734,213,300.931,088,331,674.611,085,404,379.061,085,404,379.06
  期末现金及现金等价物余额663,522,224.91734,213,300.93747,584,795.32808,334,774.66
补充资料:
  净利润-768,346,157.39-454,575,661.01
  资产减值准备-27,737,334.93-29,236,268.77
  固定资产和投资性房地产折旧-552,923,990.02-273,102,983.68
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-552,923,990.02-273,102,983.68
  无形资产摊销-19,627,677.52-9,732,525.89
  长期待摊费用摊销-878,253.01-439,126.5
  处置固定资产、无形资产和其他长期资产的损失--345,957.83--352,143.38
  固定资产报废损失-1,390,522.65-859,508.76
  公允价值变动损失-1,483,217.89--4,354.45
  财务费用-40,474,674.98-18,204,971.56
  投资损失-2,071,203.43--501,508.54
  递延所得税--922,003.27--2,940,164.75
  其中:递延所得税资产减少--922,003.27--3,026,396.23
    递延所得税负债增加---86,231.48
  存货的减少--182,286,435.89-219,184,289.14
  经营性应收项目的减少--527,477,968.93--434,368,262.14
  经营性应付项目的增加--162,487,727.15--184,487,916.05
  其他--7,297,177.5--
  不涉及现金收支的投资和筹资活动金额其他项目-10,162,374.09--
  现金的期末余额-734,213,300.93-808,334,774.66
  减:现金的期初余额-1,088,331,674.61-1,085,404,379.06
  现金及现金等价物的净增加额--354,118,373.68--277,069,604.4
公告日期2026-04-232026-03-312025-10-282025-08-26
审计意见(境内)标准无保留意见
TOP↑